Back to top
more

Nu Skin Enterprises (NUS)

(Delayed Data from NYSE)

$6.55 USD

6.55
991,294

+0.10 (1.55%)

Updated Nov 8, 2024 04:00 PM ET

After-Market: $6.54 -0.01 (-0.15%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 16% (211 out of 250)

Industry: Cosmetics

Balance Sheet

Research for NUS

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Nu Skin Enterprises, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 268 279 355 424 344
Receivables 73 47 41 63 50
Notes Receivable 0 0 0 0 0
Inventories 280 346 400 314 276
Other Current Assets 81 88 77 102 70
Total Current Assets 702 760 873 903 740
Net Property & Equipment 433 445 454 468 454
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 336 273 283 293 277
Deposits & Other Assets 245 244 175 138 154
Total Assets 1,806 1,821 1,906 1,957 1,769
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 44 54 50 66 39
Current Portion Long-Term Debt 25 25 108 30 28
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 260 280 372 447 290
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 329 359 530 543 357
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 478 377 269 305 334
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 107 110 106 102 97
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 985 924 994 1,063 894
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 622 613 602 580 558
Retained Earnings 1,870 1,940 1,912 1,841 1,728
Other Equity -100 -87 -74 -65 -85
Treasury Stock 1,570 1,569 1,527 1,462 1,325
Total Shareholder's Equity 822 897 913 894 875
Total Liabilities & Shareholder's Equity 1,806 1,821 1,906 1,957 1,769
Total Common Equity 822 897 913 894 875
Shares Outstanding 49.50 49.50 49.90 50.90 55.60
Book Value Per Share 16.61 18.13 18.29 17.57 15.74

Fiscal Year End for Nu Skin Enterprises, Inc falls in the month of December.

All items in Millions except Per Share data.

9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023
Assets          
Cash & Equivalents 238 233 221 268 250
Receivables 69 72 67 73 77
Notes Receivable NA 0 0 0 0
Inventories 248 244 265 280 291
Other Current Assets 99 106 94 81 83
Total Current Assets 653 654 647 702 701
Net Property & Equipment 411 412 423 433 429
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles 185 188 333 336 338
Deposits & Other Assets 248 243 246 245 238
Total Assets 1,583 1,586 1,742 1,806 1,793
Liabilities & Shareholders Equity 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023
Notes Payable NA 0 0 0 0
Accounts Payable 33 36 32 44 49
Current Portion Long-Term Debt 60 30 30 25 140
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses 247 242 247 260 245
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities 339 309 309 329 434
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt 373 428 453 478 363
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities 95 95 107 106
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities 876 900 932 985 971
Shareholders Equity 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 625 621 619 622 619
Retained Earnings 1,751 1,746 1,867 1,870 1,882
Other Equity -105 -117 -111 -100 -109
Treasury Stock 1,564 1,564 1,565 1,570 1,571
Total Shareholder's Equity 707 686 810 822 822
Total Liabilities & Shareholder's Equity 1,583 1,586 1,742 1,806 1,793
Total Common Equity 100,706 686 810 822 822
Shares Outstanding 49.70 49.70 49.70 49.50 49.40
Book Value Per Share 2,026.28 13.81 16.30 16.61 16.64